Antidiabetic Potential of Emodin in Streptozotocin-Induced Type-2 Diabetic Rats
Keywords:
Type 2 diabetes, antidiabetic activity, emodin, insulin resistance and Antioxidant enzymesAbstract
Diabetes mellitus, particularly type 2 diabetes, is a growing global health issue, often exacerbated by insulin resistance, metabolic disturbances, and inflammatory responses. Emodin, a natural anthraquinone derivative, has been widely recognized for its pharmacological properties, including its antidiabetic potential. This study investigates the therapeutic efficacy of emodin in ameliorating Type 2 diabetes in Wistar albino rats induced by streptozotocin (STZ). Male rats were divided into healthy, diabetic, and treatment groups, with diabetic groups receiving emodin (40 mg/kg body weight/day, orally) or metformin for 45 days. Diabetes induction was confirmed by elevated blood glucose levels, altered lipid profiles, and reduced insulin sensitivity. Emodin administration significantly reduced fasting blood glucose levels and improved glucose tolerance, comparable to metformin treatment. Biochemical analyses revealed that emodin restored the lipid profile, enhanced antioxidant enzyme activity, and suppressed oxidative stress markers in diabetic rats. The study revealed that emodin exhibited antidiabetic effects by regulating glucose metabolism, enhancing insulin sensitivity, and reducing oxidative stress. Data expressed as mean ± SEM showed significant differences (p<0.05) among control, diabetic control, emodin-treated, and metformin-treated groups. Emodin treatment notably improved glucose metabolism and outperformed metformin in reducing insulin resistance. These findings highlight emodin's potential as a therapeutic agent for Type 2 diabetes by targeting insulin resistance, inflammation, and metabolic dysregulation. Emodin holds promise for managing diabetes and its complications effectively.
Downloads
Metrics
References
Forbes, J. M., & Cooper, M. E. (2013). Mechanisms of diabetic complications. Physiological reviews, 93(1), 137-188.
Kharroubi, A. T., & Darwish, H. M. (2015). Diabetes mellitus: The epidemic of the century. World journal of diabetes, 6(6), 850.
Mason, S., & Wadley, G. D. (2014). Skeletal muscle reactive oxygen species: a target of good cop/bad cop for exercise and disease. Redox Report, 19(3), 97-106.
Deenadayalan, A., Subramanian, V., Paramasivan, V., Veeraraghavan, V. P., Rengasamy, G., Coiambatore Sadagopan, J., ... & Jayaraman, S. (2021). Stevioside attenuates insulin resistance in skeletal muscle by facilitating IR/IRS-1/Akt/GLUT 4 signaling pathways: An in vivo and in silico approach. Molecules, 26(24), 7689.
Dong, X., Fu, J., Yin, X., Cao, S., Li, X., Lin, L., ... & Ni, J. (2016). Emodin: a review of its pharmacology, toxicity and pharmacokinetics. Phytotherapy Research, 30(8), 1207-1218.
Yu, Y., & Zheng, G. (2017). Troxerutin protects against diabetic cardiomyopathy through NF κB/AKT/IRS1 in a rat model of type 2 diabetes. Molecular medicine reports, 15(6), 3473-3478.
Mabhida, S. E., Johnson, R., Ndlovu, M., Louw, J., Opoku, A., & Mosa, R. A. (2019). Molecular basis of the anti-hyperglycemic activity of RA-3 in hyperlipidemic and streptozotocin-induced type 2 diabetes in rats. Diabetology & Metabolic Syndrome, 11, 1-5.
Roy, J. R., Janaki, C. S., Jayaraman, S., Periyasamy, V., Balaji, T., Vijayamalathi, M., & Veeraraghavan, V. P. (2022). Effect of Carica papaya on IRS-1/Akt signaling mechanisms in High-Fat-Diet–Streptozotocin-Induced type 2 diabetic experimental rats: a mechanistic approach. Nutrients, 14(19), 4181.
Matboli, M., Saad, M., Hasanin, A. H., Saleh, L. A., Baher, W., Bekhet, M. M., & Eissa, S. (2021). New insight into the role of isorhamnetin as a regulator of insulin signaling pathway in type 2 diabetes mellitus rat model: Molecular and computational approach. Biomedicine & Pharmacotherapy, 135, 111176.
Jayaraman, S., Natarajan, S. R., Veeraraghavan, V. P., & Jasmine, S. (2023). Unveiling the anti-cancer mechanisms of calotropin: Insights into cell growth inhibition, cell cycle arrest, and metabolic regulation in human oral squamous carcinoma cells (HSC-3). Journal of Oral Biology and Craniofacial Research, 13(6), 704-713.
Xue, J., Ding, W., & Liu, Y. (2010). Anti-diabetic effects of emodin involved in the activation of PPARγ on high-fat diet-fed and low dose of streptozotocin-induced diabetic mice. Fitoterapia, 81(3), 173-177.
Pazhani, J., Chanthu, K., Jayaraman, S., & Varun, B. R. (2023). Evaluation of salivary MMP-9 in oral squamous cell carcinoma and oral leukoplakia using ELISA. Journal of Oral and Maxillofacial Pathology, 27(4), 649-654.
Bing, S., Haoqiang, Z., Chunyu, M., Yali, Y., Jing, W., Yumeng, G., ... & Xuezheng, L. (2018). The effects of emodin on insulin resistance in KKAy mice with diabetes mellitus. Pharmacognosy Magazine, 14(56).
Wu, Z., Chen, Q., Ke, D., Li, G., & Deng, W. (2014). Emodin protects against diabetic cardiomyopathy by regulating the AKT/GSK-3β signaling pathway in the rat model. Molecules, 19(9), 14782-14793.
Sagar, S., Ramani, P., Moses, S., Gheena, S., & Selvaraj, J. (2024). Correlation of salivary cytokine IL-17A and 1, 25 dihydroxycholecalciferol in patients undergoing orthodontic treatment. Odontology, 1-10.
Malloy, H. T., & Evelyn, K. A. (1937). The determination of bilirubin with the photoelectric colorimeter. Journal of biological Chemistry, 119(2), 481-490.
Kaplan, M., Muraca, M., Hammerman, C., Rubaltelli, F. F., Vilei, M. T., Vreman, H. J., & Stevenson, D. K. (2002). Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice. Pediatrics, 110(4), e47-e47.
Devasagayam TP, Tarachand U. Decreased lipid peroxidation in the rat kidney during gestation. Biochem Biophys Res Commun. 1987 May 29;145(1):134-8.
Pick E, Keisari Y. Superoxide anion and hydrogen peroxide production by chemically elicited peritoneal macrophages--induction by multiple nonphagocytic stimuli. Cell Immunol. 1981 Apr;59(2):301-18.
Puntarulo S, Cederbaum AI. Effect of oxygen concentration on microsomal oxidation of ethanol and generation of oxygen radicals. Biochem J. 1988 May 1;251(3):787-94.
Selvaraj, J., Sathish, S., Mayilvanan, C., & Balasubramanian, K. (2013). Excess aldosterone-induced changes in insulin signaling molecules and glucose oxidation in gastrocnemius muscle of adult male rat. Molecular and cellular biochemistry, 372, 113-126.
Jayaraman, S., Natarajan, S. R., Ponnusamy, B., Veeraraghavan, V. P., & Jasmine, S. (2023). Unlocking the potential of beta sitosterol: Augmenting the suppression of oral cancer cells through extrinsic and intrinsic signalling mechanisms. The Saudi Dental Journal, 35(8), 1007-1013.
Gandhi, G. R., Stalin, A., Balakrishna, K., Ignacimuthu, S., Paulraj, M. G., & Vishal, R. (2013). Insulin sensitization via partial agonism of PPARγ and glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway by embelin in type 2 diabetic rats. Biochimica et Biophysica Acta (BBA)-General Subjects, 1830(1), 2243-2255.
Guirgis, A. A., Habib, D. F., Hanna, H., & Mahmoud, R. A. (2021). Molecular and Biochemical Studies on Some Natural Compounds and Their Effect on the Streptozotocin-induced Diabetic Rats and Their Role in Treatment. Journal of Bioscience and Applied Research, 7(4), 160-175.
Sruthi, M. A., Mani, G., Ramakrishnan, M., & Selvaraj, J. (2023). Dental caries as a source of Helicobacter pylori infection in children: An RT‐PCR study. International Journal of Paediatric Dentistry, 33(1), 82-88.
Indu, S., Vijayalakshmi, P., Selvaraj, J., & Rajalakshmi, M. (2021). Novel triterpenoids from Cassia fistula stem bark depreciates STZ-induced detrimental changes in IRS-1/Akt-mediated insulin signaling mechanisms in type-1 diabetic rats. Molecules, 26(22), 6812.
Fathima, J. S., Jayaraman, S., Sekar, R., & Syed, N. H. (2024). The role of MicroRNAs in the diagnosis and treatment of oral premalignant disorders. Odontology, 1-10.
Cao, Y., Chang, S., Dong, J., Zhu, S., Zheng, X., Li, J., ... & Zhang, Y. (2016). Emodin ameliorates high-fat-diet induced insulin resistance in rats by reducing lipid accumulation in skeletal muscle. European Journal of Pharmacology, 780, 194-201.
Krishnan, R. P., Pandiar, D., Ramani, P., & Jayaraman, S. (2025). Molecular profiling of oral epithelial dysplasia and oral squamous cell carcinoma using next generation sequencing. Journal of Stomatology, Oral and Maxillofacial Surgery, 126(4), 102120.
He, L., Zhang, F. J., Li, H. Y., Li, L., Song, L. G., Mao, Y., ... & Kang, Z. Q. (2021). Anti-diabetic role of adropin in streptozotocin induced diabetic rats via alteration of PI3K/Akt and insulin signaling pathway. Journal of Oleo Science, 70(5), 657-664.
Yasothkumar, D., Ramani, P., Jayaraman, S., Ramalingam, K., & Tilakaratne, W. M. (2024). Expression Profile of Circulating Exosomal microRNAs in Leukoplakia, Oral Submucous Fibrosis, and Combined Lesions of Leukoplakia and Oral Submucous Fibrosis. Head and Neck Pathology, 18(1), 28.
Kumar Datusalia, A., & Sunder Sharma, S. (2016). NF-κB inhibition resolves cognitive deficits in experimental type 2 diabetes mellitus through CREB and glutamate/GABA neurotransmitters pathway. Current neurovascular research, 13(1), 22-32.
Sajan, M. P., Standaert, M. L., Rivas, J., Miura, A., Kanoh, Y., Soto, J., ... & Farese, R. V. (2009). Role of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NFκB) in liver of rodents used as a model of diabetes, and relationships to hyperlipidaemia and insulin resistance. Diabetologia, 52, 1197-1207.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.